WINCOAT WT-NAQ represents advanced enteric film coating technology specifically designed for aqueous application systems. This premium coating solution addresses traditional challe...

WINCOAT WT-NAQ represents advanced enteric film coating technology specifically designed for aqueous application systems. This premium coating solution addresses traditional challenges associated with solvent-based coatings by offering a safer, environmentally conscious alternative without compromising performance. The pH-dependent film remains insoluble in acidic stomach conditions (pH 1-3) while dissolving rapidly in the near-neutral pH of the small intestine (pH 5.5+). This precise release mechanism ensures optimal drug delivery, protecting active ingredients from gastric acid and enzymes while enabling targeted release where absorption is most effective. The ready-to-use formulation streamlines production processes, reducing preparation time and minimizing potential application errors for modern manufacturing operations.

WINCOAT WT-NAQ serves pharmaceutical and nutraceutical manufacturers producing solid oral dosage forms requiring gastric protection. This includes prescription medication producers working with acid-sensitive drugs like proton pump inhibitors, specific antibiotics, and enzyme preparations. Nutraceutical companies utilize this coating for sensitive supplements including probiotics and fish oils to maintain viability until intestinal delivery. Contract manufacturing organizations and generic drug manufacturers value this coating for its reliability and consistency in producing bioequivalent products. The technology also benefits veterinary pharmaceuticals where precise dosing and protection are equally critical for animal health applications and medication effectiveness.

For manufacturing operations, WINCOAT WT-NAQ delivers significant value through enhanced production efficiency and superior end-product quality. The aqueous system reduces operational costs associated with solvent handling, ventilation requirements, and recovery systems while minimizing environmental compliance burdens. Consistent film formation and excellent adhesion properties result in higher production yields and reduced rejection rates, directly impacting operational profitability. Product reliability is supported by stringent quality control measures and batch-to-batch consistency, ensuring compliance with international pharmacopeial standards. The formulation's performance characteristics provide competitive advantages in markets where product differentiation and consistent quality are essential purchasing considerations.

Key Features:
- pH-dependent dissolution ensures reliable gastric protection and intestinal release
- Aqueous-based formulation eliminates organic solvents and associated hazards
- Ready-to-use system reduces preparation time and simplifies manufacturing
- Excellent film-forming properties provide uniform coating consistency
- Compatibility with synthetic and natural colors allows product identification

Benefits:
- Ensures precise drug delivery to intestinal absorption sites
- Creates safer working environment by eliminating solvent exposure
- Increases production efficiency through simplified processing
- Delivers consistent dosage performance and reliable protection
- Enables product differentiation through color customization options